After residency, I spent time on the faculty at MD Anderson Cancer Center treating hematologic malignancies (leukemia, lymphoma and multiple myeloma). I have considerable experience treating this patient population. Because many lymphomas are highly curable, management of long term side effects from treatment is essential. I have used many different treatment techniques and modalities to minimize radiation dose to normal structures, thereby minimizing late effects from treatment. I also have a great deal of experience working with cutaneous lymphomas and the management of this category of lymphomas.
I am a GU radiation oncologist who, in addition to providing external beam treatment for my prostate cancer patients, is building the HDR prostate brachytherapy program at USC. I worked with people from Memorial Sloan Kettering and Fox Chase Cancer Center to develop a state-of-the-art HDR treatment program that allows excellent tumor control with maximal convenience for patients and minimal treatment related toxicities.
Satkunasivam R, Kim AE, Desai M, Nguyen MM, Quinn DI, Ballas L, Lewinger JP, Stern MC, Hamilton AS, Aron M, Gill IS. Radical Prostatectomy or External Beam Radiation Therapy vs No Local Therapy for Survival Benefit in Metastatic Prostate Cancer: A SEER-Medicare Analysis. J Urol. 2015 Aug; 194(2):378-85. View in: PubMed
Ballas LK, Hu BR, Quinn DI. Chromoplexy and hypoxic microenvironment drives prostate cancer. Lancet Oncol. 2014 Dec; 15(13):1419-21. View in: PubMed
Dabaja B, Wang Z, Stovall M, Baker JS, Smith SA, Khan M, Ballas L, Salehpour MR. Involved field radiation for Hodgkin's lymphoma: the actual dose to breasts in close proximity. Med Dosim. 2012; 37(4):374-82. View in: PubMed
Shihadeh F, Reed V, Faderl S, Medeiros LJ, Mazloom A, Hadziahmetovic M, Kantarjian H, Allen P, Ballas L, Pierce S, Dabaja B. Cytogenetic profile of patients with acute myeloid leukemia and central nervous system disease. Cancer. 2012 Jan 1; 118(1):112-7. View in: PubMed